venture capital | Science and Enterprise

Many thanks @SciSeeker https://t.co/uQy4yl5pQb
about 15 hours ago
New post on Science and Enterprise: Taking a Break https://t.co/QgH851GMZX #Science #Business
about 4 days ago
Total venture capital funding in the U.S. for first six months of 2019 reached levels not seen since the year 2000,… https://t.co/cGSC6j1Xl8
about 4 days ago
New post on Science and Enterprise: Infographic – U.S. Venture Funds Near 20-Year Highs https://t.co/mIkraoGRAH #Science #Business
about 4 days ago
A set of computational tools developed at Purdue University enables public safety agencies to monitor potentially c… https://t.co/NHSLm9YBBG
about 5 days ago

Infographic – U.S. Venture Funds Near 20-Year Highs

By Alan, on July 19th, 2019%

Total venture capital funding in the U.S. for first six months of 2019 reached levels not seen since the year 2000, the waning days of the dot-com era. . . . → Read More: Infographic – U.S. Venture Funds Near 20-Year Highs

Immunotherapy Biotech Gains $325M in Venture Funds

By Alan, on July 9th, 2019%

A biotechnology enterprise developing personalized treatments for cancer and infectious diseases is raising $325 million in its second venture funding round. . . . → Read More: Immunotherapy Biotech Gains $325M in Venture Funds

Stem Cell Start-Up Raises $250M in Venture Funds

By Alan, on July 2nd, 2019%

A company begun last year to create cancer therapies from banked, off-the-shelf stem cells is raising $250 million in its first round of venture financing. . . . → Read More: Stem Cell Start-Up Raises $250M in Venture Funds

A.I. Chip Start-Up Raises $23M in Early Funds

By Alan, on June 26th, 2019%

A start-up enterprise is developing computer chips designed to run artificial intelligence, or A.I., applications but with an architecture it says can avoid memory logjams. . . . → Read More: A.I. Chip Start-Up Raises $23M in Early Funds

Company Launches Attacking Cancer Proteins, Lands $67M

By Alan, on June 25th, 2019%

A new enterprise is starting-up to develop treatments that target cancer-causing proteins considered unreachable with current therapies. . . . → Read More: Company Launches Attacking Cancer Proteins, Lands $67M

Foundation Supports Muscular Dystrophy RNA Therapy

By Alan, on June 12th, 2019%

A university spin-off company is receiving a foundation grant to advance its Crispr technology targeting RNA to treat a form of muscular dystrophy. . . . → Read More: Foundation Supports Muscular Dystrophy RNA Therapy

Liquid Biopsy Screening Start-Up Launches, Gains $110M

By Alan, on May 30th, 2019%

A new enterprise is starting up, developing early-stage cancer screening with a single blood test, based on research at Johns Hopkins University. . . . → Read More: Liquid Biopsy Screening Start-Up Launches, Gains $110M

Viral Disease Biotech Joins ElevateBio, Gains $120M

By Alan, on May 22nd, 2019%

A biotechnology company developing immunotherapies for viral diseases is joining the ElevateBio consortium providing manufacturing for cell and gene therapies. . . . → Read More: Viral Disease Biotech Joins ElevateBio, Gains $120M

Start-Up to Use Stem Cells for Hearing Loss

By Alan, on May 20th, 2019%

A new enterprise in the U.K. is creating treatments with stem cells to repair damaged nerve cells in the inner ear that causes hearing loss. . . . → Read More: Start-Up to Use Stem Cells for Hearing Loss

Company Helps Labs Build Gene, Cell Therapy Businesses

By Alan, on May 14th, 2019%

A new company formed offering full-scale facilities to develop cell and gene therapy products spun-off from academic research labs. . . . → Read More: Company Helps Labs Build Gene, Cell Therapy Businesses

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise